about
Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant ApproachesFrom Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders.Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapyGerm Cell Origins of Posttraumatic Stress Disorder Risk: The Transgenerational Impact of Parental Stress ExperienceTargeting memory processes with drugs to prevent or cure PTSDExecutive Dysfunctions: The Role in Attention Deficit Hyperactivity and Post-traumatic Stress Neuropsychiatric DisordersDiagnostic Biomarkers for Posttraumatic Stress Disorder: Promising Horizons from Translational Neuroscience ResearchOverexpression of Forebrain CRH During Early Life Increases Trauma Susceptibility in Adulthood.An analysis of gene expression in PTSD implicates genes involved in the glucocorticoid receptor pathway and neural responses to stressImmune status influences fear and anxiety responses in mice after acute stress exposure.Differential Genetic and Epigenetic Regulation of catechol-O-methyltransferase is Associated with Impaired Fear Inhibition in Posttraumatic Stress Disorder.Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviorsContextual fear conditioning in virtual reality is affected by 5HTTLPR and NPSR1 polymorphisms: effects on fear-potentiated startleEpidemiology and genetics of common mental disorders in the general population: the PEGASUS-Murcia project.Neuroimaging genetic approaches to Posttraumatic Stress Disorder.The relationship between glucocorticoid receptor polymorphisms, stressful life events, social support, and post-traumatic stress disorder.The negative impact of single prolonged stress (SPS) on bone development in mice.Genetic approaches to understanding post-traumatic stress disorder.Core modular blood and brain biomarkers in social defeat mouse model for post traumatic stress disorderDeployment and post-deployment experiences in OEF/OIF veterans: relationship to gray matter volume.Propranolol, post-traumatic stress disorder, and intensive care: incorporating new advances in psychiatry into the ICURORA and posttraumatic stress trajectories: main effects and interactions with childhood physical abuse history.Effects of persisting emotional impact from child abuse and norepinephrine transporter genetic variation on antidepressant efficacy in major depression: a pilot study.Perspectives on creating clinically relevant blast models for mild traumatic brain injury and post traumatic stress disorder symptoms.Higher FKBP5, COMT, CHRNA5, and CRHR1 allele burdens are associated with PTSD and interact with trauma exposure: implications for neuropsychiatric research and treatment.Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder.How and why does the 5-HTTLPR gene moderate associations between maternal unresponsiveness and children's disruptive problems?Fear extinction and BDNF: translating animal models of PTSD to the clinic.Gene-by-social-environment interaction (GxSE) between ADCYAP1R1 genotype and neighborhood crime predicts major depression symptoms in trauma-exposed womenPosttraumatic stress disorder across two generations: concordance and mechanisms in a population-based sample.Consumer perspectives on genetic testing for psychiatric disorders: the attitudes of veterans with posttraumatic stress disorder and their familiesPrediction of Possible Biomarkers and Novel Pathways Conferring Risk to Post-Traumatic Stress DisorderBiomarkers of post-deployment resilience among military service membersUnderstanding resilience.The association of a novel haplotype in the dopamine transporter with preschool age posttraumatic stress disorder.Interindividual Variability in Stress Susceptibility: A Role for Epigenetic Mechanisms in PTSD.The role of limbic system irritability in linking history of childhood maltreatment and psychiatric outcomes in low-income, high-risk women: moderation by FK506 binding protein 5 haplotypeTemporal factors in the extinction of fear in inbred mouse strains differing in extinction efficacy.Epigenomic Mechanisms of Early Adversity and HPA Dysfunction: Considerations for PTSD Research.PTSD recovery, spatial processing, and the val66met polymorphism.
P2860
Q26738789-F5067F2E-25F5-4BAE-98BD-AB9AFCE4AD7FQ26851172-81CC2B5D-4096-4D38-BD46-82A118CDE2BDQ26860173-8D64ED13-36CB-48D3-BC39-61E4B9EAD87AQ26863495-5C63C2A1-75A5-47BC-8A13-D907C7751333Q27016155-C70842E2-0B06-4A65-94BE-592183F8BBA8Q28073484-1B167045-F676-4136-9C81-28DA4A93BFA8Q28082087-5FE90203-6BD8-4D60-AE74-2099E5C16730Q30357783-71E7031A-27F6-470E-AFD1-A66169D95981Q30380502-AD072881-A69E-4A5C-AA6E-E64918899A21Q30412919-DB902E3E-EB86-42D8-9938-FC402905547DQ30429540-B3BCAD51-321F-4E76-A469-4A1967C5D69FQ30433318-2C895E04-A5B2-431B-BA74-8E5FFFC4D0E2Q30455158-5B5C8697-3DBA-482A-949E-D77156D8E76DQ30558941-328EAD7D-602C-4619-A462-3DC7C5C8F419Q31083781-40AF9039-A14B-407D-9E6C-252751186FAAQ34108841-BEDA786B-E661-4B54-84C8-0C3FDA1A0D8AQ34727297-AF3DAE92-DF42-4661-A33E-3CA388957799Q34940724-C34B323C-9195-4753-8943-E02B97D0152CQ34958642-FA3FE23A-E21E-49A3-BC49-EE1F147E46B1Q34995159-5FEAF8A0-3194-4838-8C4A-677FF64A4AC6Q35091910-344CAC7A-7EC6-4707-8212-DBDE8CFA35CBQ35169161-8457BA07-2CA1-4BE5-831E-47FDD53F8A36Q35579226-675C9F7E-E251-4EF4-A925-90D0CC670828Q35810092-C8A03BA4-22CF-4714-9F64-9C9784761B4DQ35905819-F9A84D65-FEA4-412F-9B8A-244139909B9BQ36019618-96FBF14A-4470-4D1F-89F8-C551FCF57561Q36019872-A7FD72BF-958A-4890-B305-C1C28C5159B1Q36074354-97CF8979-4473-4262-9C5B-6A859655CB10Q36103821-D31FD96F-F5F6-457C-AC68-AC180B98F62CQ36141296-4018DD8B-9306-454C-B777-A66DCA8D2C31Q36225319-AD3256AC-116F-4378-8204-A9D7DA3A710DQ36229576-847ADFDC-5C7E-4D17-A867-533C509E4C36Q36486307-73831E14-B2C1-4FEF-BF64-3BAA9A716B2EQ36612228-4DC82851-1CA7-45EC-9418-C45CA56553CBQ36853136-46DD312F-20BA-4F3D-81D4-325E258AA0A3Q36955907-220E005B-4CE3-4719-81BF-2FD8B475CA36Q36969082-3684BE6C-31A8-4455-BE47-59941CF2B3EFQ37053613-4E624FCE-EB90-48F8-B52C-83A03694184EQ37199252-71FD4594-D540-43DA-83F0-3DF292D09829Q37604105-35DF604F-5E60-4B9A-9435-E58BED14D091
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
PTSD and gene variants: new pathways and new thinking
@nl
PTSD and gene variants: new pathways and new thinking.
@ast
PTSD and gene variants: new pathways and new thinking.
@en
type
label
PTSD and gene variants: new pathways and new thinking
@nl
PTSD and gene variants: new pathways and new thinking.
@ast
PTSD and gene variants: new pathways and new thinking.
@en
prefLabel
PTSD and gene variants: new pathways and new thinking
@nl
PTSD and gene variants: new pathways and new thinking.
@ast
PTSD and gene variants: new pathways and new thinking.
@en
P2093
P2860
P3181
P1433
P1476
PTSD and gene variants: new pathways and new thinking
@en
P2093
Kelly Skelton
Seth D Norrholm
Tanja Jovanovic
P2860
P304
P3181
P356
10.1016/J.NEUROPHARM.2011.02.013
P407
P577
2011-02-26T00:00:00Z